The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21.2 - Manufacture of pharmaceutical preparations
700 - 1,000 jobs Number of planned job losses
Announcement Date
18 March 2013
Employment effect (start)
Foreseen end date
31 December 2016
Description
Pharmaceutical company AstraZeneca has announced that it plans to cut 700 jobs from its UK workforce by 2016 as part of global restructuring plans (see AstraZeneca-WO2013). The company intends to relocate staff from the Alderly Edge and London sites to a new facility in Cambridge. There are also plans to relocate 300 roles outside the UK.
Sources
18 March 2013: Financial Times
Citation
Eurofound (2013), Astra Zeneca, Relocation in United Kingdom, factsheet number 75204, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/75204.